180 related articles for article (PubMed ID: 19643844)
21. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
22. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
Wessels MR; Haft RF; Heggen LM; Rubens CE
Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
[TBL] [Abstract][Full Text] [Related]
23. The sialyl-O-acetylesterase NanS of Tannerella forsythia encompasses two catalytic modules with different regiospecificity for O7 and O9 of sialic acid.
Albers M; Schröter L; Belousov S; Hartmann M; Grove M; Abeln M; Mühlenhoff M
Glycobiology; 2021 Sep; 31(9):1176-1191. PubMed ID: 33909048
[TBL] [Abstract][Full Text] [Related]
24. Separate pathways for O acetylation of polymeric and monomeric sialic acids and identification of sialyl O-acetyl esterase in Escherichia coli K1.
Steenbergen SM; Lee YC; Vann WF; Vionnet J; Wright LF; Vimr ER
J Bacteriol; 2006 Sep; 188(17):6195-206. PubMed ID: 16923886
[TBL] [Abstract][Full Text] [Related]
25. The Sialic Acid Binding Activity of Human Parainfluenza Virus 3 and Mumps Virus Glycoproteins Enhances the Adherence of Group B Streptococci to HEp-2 Cells.
Tong J; Fu Y; Meng F; Krüger N; Valentin-Weigand P; Herrler G
Front Cell Infect Microbiol; 2018; 8():280. PubMed ID: 30175075
[TBL] [Abstract][Full Text] [Related]
26. Chemoenzymatic synthesis of Neu5Ac9NAc-containing α2-3- and α2-6-linked sialosides and their use for sialidase substrate specificity studies.
Li W; Xiao A; Li Y; Yu H; Chen X
Carbohydr Res; 2017 Nov; 451():51-58. PubMed ID: 28961426
[TBL] [Abstract][Full Text] [Related]
27. L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.
Aoyagi Y; Adderson EE; Rubens CE; Bohnsack JF; Min JG; Matsushita M; Fujita T; Okuwaki Y; Takahashi S
Infect Immun; 2008 Jan; 76(1):179-88. PubMed ID: 17938215
[TBL] [Abstract][Full Text] [Related]
28. Sialic acid-dependent interaction of group B streptococci with influenza virus-infected cells reveals a novel adherence and invasion mechanism.
Tong J; Fu Y; Wu NH; Rohde M; Meng F; Valentin-Weigand P; Herrler G
Cell Microbiol; 2018 Apr; 20(4):. PubMed ID: 29272058
[TBL] [Abstract][Full Text] [Related]
29. Sialic Acid-Siglec-E Interactions During
Mukherjee K; Khatua B; Mandal C
Front Immunol; 2020; 11():332. PubMed ID: 32184783
[No Abstract] [Full Text] [Related]
30. Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus.
Chang YC; Olson J; Louie A; Crocker PR; Varki A; Nizet V
J Mol Med (Berl); 2014 Sep; 92(9):951-9. PubMed ID: 24788876
[TBL] [Abstract][Full Text] [Related]
31. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
[TBL] [Abstract][Full Text] [Related]
32. A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.
Saito M; Yamamoto S; Ozaki K; Tomioka Y; Suyama H; Morimatsu M; Nishijima KI; Yoshida SI; Ono E
Microb Pathog; 2016 Oct; 99():106-110. PubMed ID: 27544323
[TBL] [Abstract][Full Text] [Related]
33. Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus.
Wasik BR; Barnard KN; Ossiboff RJ; Khedri Z; Feng KH; Yu H; Chen X; Perez DR; Varki A; Parrish CR
mSphere; 2017; 2(5):. PubMed ID: 28904995
[TBL] [Abstract][Full Text] [Related]
34. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
Razi N; Varki A
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
[TBL] [Abstract][Full Text] [Related]
35. Capsular sialic acid limits C5a production on type III group B streptococci.
Takahashi S; Aoyagi Y; Adderson EE; Okuwaki Y; Bohnsack JF
Infect Immun; 1999 Apr; 67(4):1866-70. PubMed ID: 10085029
[TBL] [Abstract][Full Text] [Related]
36. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
Carlin AF; Uchiyama S; Chang YC; Lewis AL; Nizet V; Varki A
Blood; 2009 Apr; 113(14):3333-6. PubMed ID: 19196661
[TBL] [Abstract][Full Text] [Related]
37. Sialic acid O-acetylation: From biosynthesis to roles in health and disease.
Visser EA; Moons SJ; Timmermans SBPE; de Jong H; Boltje TJ; Büll C
J Biol Chem; 2021 Aug; 297(2):100906. PubMed ID: 34157283
[TBL] [Abstract][Full Text] [Related]
38. Capsular Sialyltransferase Specificity Mediates Different Phenotypes in
Roy D; Takamatsu D; Okura M; Goyette-Desjardins G; Van Calsteren MR; Dumesnil A; Gottschalk M; Segura M
Front Microbiol; 2018; 9():545. PubMed ID: 29666608
[TBL] [Abstract][Full Text] [Related]
39. Complexity and Diversity of the Mammalian Sialome Revealed by Nidovirus Virolectins.
Langereis MA; Bakkers MJ; Deng L; Padler-Karavani V; Vervoort SJ; Hulswit RJ; van Vliet AL; Gerwig GJ; de Poot SA; Boot W; van Ederen AM; Heesters BA; van der Loos CM; van Kuppeveld FJ; Yu H; Huizinga EG; Chen X; Varki A; Kamerling JP; de Groot RJ
Cell Rep; 2015 Jun; 11(12):1966-78. PubMed ID: 26095364
[TBL] [Abstract][Full Text] [Related]
40. Sialic acid utilization by bacterial pathogens.
Severi E; Hood DW; Thomas GH
Microbiology (Reading); 2007 Sep; 153(Pt 9):2817-2822. PubMed ID: 17768226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
